<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04657185</url>
  </required_header>
  <id_info>
    <org_study_id>00000375</org_study_id>
    <nct_id>NCT04657185</nct_id>
  </id_info>
  <brief_title>Reducing Perioperative S. Aureus Transmission Via OR PathTrac</brief_title>
  <official_title>Reducing Perioperative S. Aureus Transmission Via Use of an Evidence-Based, Multimodal Program Driven by an Innovative Software Platform (OR PathTrac)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Georgetown University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>RDB Bioinformatics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Trustees of Dartmouth College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Georgetown University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Healthcare-associated infections (HAIs) occur frequently and are associated with patient&#xD;
      harm. It is important that healthcare facilities take the necessary steps to prevent the&#xD;
      spread of resistant bacteria. ESKAPE bacteria (Enterococcus, S. aureus, Klebsiella,&#xD;
      Acinetobacter, Pseudomonas, and Enterobacter spp.) are particularly pathogenic. Isolation of&#xD;
      these pathogens from intraoperative reservoirs has been associated with postoperative&#xD;
      infection development (i.e. surgical site infections). This project involves implementation&#xD;
      of a software platform and bacterial collection system (OR PathTrac) that leverages the&#xD;
      epidemiology of intraoperative bacterial transmission to guide dynamic, prospective&#xD;
      improvements in perioperative infection control measures. We will assess the effectiveness of&#xD;
      OR PathTrac feedback in optimizing an evidence-based, multifaceted, perioperative infection&#xD;
      control program.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our objective was to analyze the impact of surveillance feedback optimization of a&#xD;
      multifaceted, perioperative infection control program on S. aureus transmission and SSIs. A&#xD;
      multifaceted infection control program was implemented over 8 months (November 2018 to June&#xD;
      2019). A prospective cohort impact study was then conducted over 8 months (July 2019 to March&#xD;
      2020) to compare the incidence of within-case S. aureus transmission (primary outcome) and&#xD;
      surgical site infection (secondary outcome) before (4.5 months) and after (3.5 months)&#xD;
      implementation of surveillance feedback.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 15, 2019</start_date>
  <completion_date type="Actual">March 20, 2020</completion_date>
  <primary_completion_date type="Actual">March 20, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>within-case S. aureus transmission</measure>
    <time_frame>From patient entry into the operating room until case end, up to 6 hours</time_frame>
    <description>S. aureus transmission events detected within a surgical case</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>surgical site infection</measure>
    <time_frame>Up to 90 days following surgery</time_frame>
    <description>evidence of infection (office note documentation with anti-infective order and/or isolation of one or more potentially pathogenic organisms</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">804</enrollment>
  <condition>S. Aureus Transmission</condition>
  <condition>Surgical Site Infection</condition>
  <arm_group>
    <arm_group_label>Before OR PathTrac Feedback</arm_group_label>
    <description>Patients undergoing surgery with an evidence-based, multifaceted, perioperative infection control program in place but without OR PathTrac feedback optimization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>After OR PathTrac Feedback</arm_group_label>
    <description>Patients undergoing surgery with an evidence-based, multifaceted, perioperative infection control program in place AND OR PathTrac feedback optimization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OR PathTrac Feedback Optimization</intervention_name>
    <description>OR PathTrac (RDB Bioinformatics, Omaha, NE 68154) uses a systematic phenotypic approach leveraging temporal association to monitor 13 anesthesia work area reservoirs proven to be associated with high-risk intraoperative bacterial transmission events and subsequent infection development.</description>
    <arm_group_label>After OR PathTrac Feedback</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      S. aureus pathogens collected were assigned a unique identification number and stored for&#xD;
      future analysis.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing surgery requiring anesthesia and intravascular access.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients requiring anesthesia and intravenous catheter placement.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pediatric patients, without requirement of anesthesia and/or intravenous catheter&#xD;
             placement.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Georgetown University</name>
      <address>
        <city>Georgetown</city>
        <state>District of Columbia</state>
        <zip>20057</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 1, 2020</study_first_submitted>
  <study_first_submitted_qc>December 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2020</study_first_posted>
  <last_update_submitted>December 1, 2020</last_update_submitted>
  <last_update_submitted_qc>December 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transmission</keyword>
  <keyword>surgical site infection</keyword>
  <keyword>s. aureus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Other researchers must submit a research proposal to be reviewed by Dr. Wall for determination of release.</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>One year after publication the data will become available and will remain available for one year.</ipd_time_frame>
    <ipd_access_criteria>Submission of a research proposal to be reviewed by Dr. Wall.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

